Verastem reported $-0.44 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Curis USD -11.82 13.04 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 3.09 1.28 Jun/2026
Laboratory Of America USD 4.99 0.74 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
Verastem USD -0.44 0.04 Mar/2026